COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

STOP AF First

Purpose of Study

Provide data demonstrating the safety and effectiveness of the Arctic Front Advance Cardiac CryoAblation Catheter for the treatment of recurrent symptomatic paroxysmal atrial fibrillation with the requirement that subjects be drug refractory

Trial Status

In follow up

Duration of Participation

Age 18-80, diagnosis of symptomatic paroxysmal atrial fibrillation

Contact Name: Sara Burg, RN

Contact Phone: 515-633-3845

Contact Email: scburg@iowaheart.com